ES500199A0 - Un procedimiento para preparar una vacuna de virus de la ra-bia inactivados - Google Patents

Un procedimiento para preparar una vacuna de virus de la ra-bia inactivados

Info

Publication number
ES500199A0
ES500199A0 ES500199A ES500199A ES500199A0 ES 500199 A0 ES500199 A0 ES 500199A0 ES 500199 A ES500199 A ES 500199A ES 500199 A ES500199 A ES 500199A ES 500199 A0 ES500199 A0 ES 500199A0
Authority
ES
Spain
Prior art keywords
bia
vaccine
inactivated
viruses
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES500199A
Other languages
English (en)
Spanish (es)
Other versions
ES8202357A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp SRL
Original Assignee
Norden Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norden Laboratories Inc filed Critical Norden Laboratories Inc
Publication of ES8202357A1 publication Critical patent/ES8202357A1/es
Publication of ES500199A0 publication Critical patent/ES500199A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/819—Viral vaccine for feline species, e.g. cats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES500199A 1980-07-30 1981-03-09 Un procedimiento para preparar una vacuna de virus de la ra-bia inactivados Granted ES500199A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/174,306 US4347239A (en) 1980-07-30 1980-07-30 Inactivated rabies vaccine for veterinary use

Publications (2)

Publication Number Publication Date
ES8202357A1 ES8202357A1 (es) 1982-01-16
ES500199A0 true ES500199A0 (es) 1982-01-16

Family

ID=22635689

Family Applications (1)

Application Number Title Priority Date Filing Date
ES500199A Granted ES500199A0 (es) 1980-07-30 1981-03-09 Un procedimiento para preparar una vacuna de virus de la ra-bia inactivados

Country Status (14)

Country Link
US (1) US4347239A (en, 2012)
EP (1) EP0044920B1 (en, 2012)
JP (1) JPS5732227A (en, 2012)
KR (1) KR840001514B1 (en, 2012)
AU (1) AU544338B2 (en, 2012)
CA (1) CA1183452A (en, 2012)
DE (1) DE3160560D1 (en, 2012)
ES (1) ES500199A0 (en, 2012)
HK (1) HK50184A (en, 2012)
IE (1) IE50889B1 (en, 2012)
NZ (1) NZ196214A (en, 2012)
PH (3) PH17383A (en, 2012)
SG (1) SG3384G (en, 2012)
ZA (1) ZA811042B (en, 2012)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664912A (en) * 1984-10-01 1987-05-12 Wiktor Tadeusz J Process for the large scale production of rabies vaccine
DE3526809A1 (de) * 1985-07-26 1987-04-02 Behringwerke Ag Tollwut-lebendimpfstoff
DE3682482D1 (de) * 1985-11-22 1991-12-19 Schweiz Serum & Impfinst Verfahren zur herstellung eines tollwutimpfstoffes und nach diesem verfahren erhaltener impfstoff.
US4990367A (en) * 1987-03-09 1991-02-05 Diamond Scientific Company Canine distemper virus vaccine
RU2134590C1 (ru) * 1997-11-24 1999-08-20 Всероссийский научно-исследовательский институт защиты животных Способ изготовления инактивированной вакцины против бешенства животных
RU2191600C1 (ru) * 2001-12-20 2002-10-27 Скичко Николай Данилович Способ получения антирабической вакцины
RU2287343C1 (ru) * 2005-05-31 2006-11-20 ОАО "Институт биотехнологий ветеринарной медицины" Способ получения антирабической вакцины
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
RU2366457C1 (ru) * 2008-02-27 2009-09-10 Государственное научное учреждение Всероссийский научно-исследовательский и технологический институт биологической промышленности РАСХН Вакцина антирабическая для животных (унирэв)
CN101846683B (zh) * 2010-06-22 2014-08-06 普莱柯生物工程股份有限公司 一种猪瘟活疫苗效力检验方法
RU2537183C2 (ru) * 2012-12-17 2014-12-27 Открытое Акционерное Общество "Институт Биотехнологий Ветеринарной Медицины" Способ получения инактивированной антирабической вакцины при безопорном выращивании клеток и репродукции в них вируса в укороченном цикле культивирования

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1030516B (de) * 1957-03-14 1958-05-22 Dr Med Gustav Seiffert Naehrboden zur Viruszuechtung
US3155589A (en) * 1958-04-14 1964-11-03 Upjohn Co Parenteral extravascular injectable vaccines for simultaneous immunization of canidae against rabies, canine distemper, and infectious canine hepatitis
US3397267A (en) * 1964-09-21 1968-08-13 Research Corp Method of producing rabies vaccine
US3423505A (en) * 1964-10-31 1969-01-21 Univ Toronto Rabies vaccine and process for preparation thereof
US3585266A (en) * 1969-02-24 1971-06-15 Dow Chemical Co Live rabies virus vaccine and method for the production thereof
US3769415A (en) * 1969-06-04 1973-10-30 Connaught Labor Ltd Method of preparing a killed vaccine for oral use
DE2162013C3 (de) 1971-12-14 1981-10-15 Johnson & Johnson, 08903 New Brunswick, N.J. Tollwut-Lebendimpfstoff, Verfahren zu seiner Herstellung nd seine Verwendung bei der Bekämpfung von Tollwut
FR2261779A1 (en) 1974-02-26 1975-09-19 Pasteur Institut Anti-rabies vaccine - obtd. from rabies virus grown on foetal calf kidney cells in a synthetic serum-free medium
FR2290220A2 (fr) 1974-11-05 1976-06-04 Pasteur Institut Nouveau vaccin antirabique
US4040904A (en) * 1975-07-21 1977-08-09 Slater Eban A Novel rabies virus vaccine and processes
DE2616407C3 (de) * 1976-04-14 1980-02-21 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines Tollwut-Impfstoffs
US4070453A (en) * 1976-06-25 1978-01-24 Syntex (U.S.A.) Inc. Diploid porcine embryonic cell strains, cultures produced therefrom, and use of said cultures for production of vaccines
GB1596653A (en) 1977-01-26 1981-08-26 Gist Brocades Nv Vaccine
BE859178A (fr) 1977-09-29 1978-01-16 Cutter Lab Souche de cellules et culture de virus

Also Published As

Publication number Publication date
AU544338B2 (en) 1985-05-23
ES8202357A1 (es) 1982-01-16
HK50184A (en) 1984-06-29
SG3384G (en) 1985-02-01
KR830005871A (ko) 1983-09-14
EP0044920B1 (en) 1983-07-06
NZ196214A (en) 1984-07-31
KR840001514B1 (ko) 1984-09-29
EP0044920A3 (en) 1982-02-17
AU6714381A (en) 1982-02-04
IE50889B1 (en) 1986-08-06
PH22308A (en) 1988-07-22
EP0044920A2 (en) 1982-02-03
PH18743A (en) 1985-09-16
ZA811042B (en) 1982-05-26
JPS5732227A (en) 1982-02-20
IE810240L (en) 1982-01-30
JPH0555487B2 (en, 2012) 1993-08-17
CA1183452A (en) 1985-03-05
US4347239A (en) 1982-08-31
PH17383A (en) 1984-08-06
DE3160560D1 (en) 1983-08-11

Similar Documents

Publication Publication Date Title
ES496358A0 (es) Un procedimiento para la preparacion de una vacuna viral vi-va estabilizada y mejorada.
ES490210A0 (es) Un procedimiento par la preparacion de una vacuna de la gri-pe.
ES529298A0 (es) Un procedimiento para la preparacion de una vacuna contra picornavirus
ES500199A0 (es) Un procedimiento para preparar una vacuna de virus de la ra-bia inactivados
NZ192477A (en) Method for protecting dogs against virulent canine parvovirus using inactivated virus vaccine
IL54390A (en) Live newcastle disease virus vaccine
DK47083D0 (da) Fremgangsmade til fremstilling af levende eller inaktiverede vacciner mod infektioes bronkitis
ES491517A0 (es) Procedimiento para preparar una vacuna de virus de gripe
FI833205A7 (fi) Menetelmä hepatitis B-virusrokotteen valmistamiseksi.
ES527588A0 (es) Un procedimiento para producir una vacuna que previene la infeccion de hepatitis b
PL206218A1 (pl) Sposob wytwarzania oslabionego zaczepu wirusa zakaznego zapalenia zoladka i jelit oraz sposob wytwarzania szczepionki
MX7528E (es) Procedimiento para la preparacion de una vacuna sintetica
MX4221E (es) Procedimiento para la preparacion de una vacuna contra la hidrofobia
ES493433A0 (es) Procedimiento para la preparacion de vacunas de virus poli- valentes
ES491710A0 (es) Un procedimiento para la preparacion de una emulsion de silicona
ES494598A0 (es) Procedimiento para preparar una vacuna inactivada de reo-vi-rus
NZ181498A (en) A live rabies virus and a vaccine there of
GB1538704A (en) Inactivated equine rhinopneumonitis virus vaccine
ES550089A0 (es) Procedimiento para producir una vacuna coadyuvada que contiene un antigeno seleccionado de proteinas, bacterias y virus.
ES507444A0 (es) Procedimiento para inactivar virus de la fiebre aftosa.
AR229930A1 (es) Procedimiento para estabilizar una vacuna que comprende un virus vivo,inactivado o atenuado de sarampion,papera,rubeola o combinaciones de los mismos
DK276380A (da) Fremgangsmaade til fremstilling af en vaccine mod infektioes kvaeg-rhinotracheitis
AU513734B2 (en) Live influenza virus vaccine
NO882206D0 (no) Fremgangsmaate for fremstilling av levende eller inaktiverte rabiesvirusvaksiner.
JPS54132226A (en) Raw virus vaccine for poutly infecting laryngth bronchus imflammatory

Legal Events

Date Code Title Description
PC1A Transfer granted

Owner name: PFIZER INC.